[Long-term treatment of chronic polyarthritis using benorylate]
- PMID: 3903
[Long-term treatment of chronic polyarthritis using benorylate]
Abstract
The antiphlogistic and analgesic effect and the compatibility of benorylate, a acetamidophenyl-acetoxy-benzoate, was tested in 33 patients with rheumatoid arthritis in an open study over a period of 6 months. Benorylate is particularly qualified for treatment of a beginning rheumatoid arthritis and for diseases with a low inflammatory activity. For patients with high inflammatory activity treatment with this substance alone is not sufficient. Side effects are mainly subjective troubles. Severe side effects were not observed. Besides the usual laboratory investigations a regular control of the blood count is advisable during long term treatment. Like with other antirheumatic drugs occasional investigations of the stool for occult blood are recommended.
Similar articles
-
[4-acetamido-phenyl-2-acetoxy-benzoate (Benorylate) in the treatment of rheumatoid arthritis].Reumatismo. 1977 Apr-Sep;29(2-3):112-5. Reumatismo. 1977. PMID: 30126 Italian. No abstract available.
-
[Treatment of chronic polyarthritis using benorylate].Med Welt. 1976 Nov 5;27(45):2162-7. Med Welt. 1976. PMID: 11392 Clinical Trial. German. No abstract available.
-
[Long-term toxicity of benorylate].Z Rheumatol. 1975 Jul-Aug;34(7-8):270-5. Z Rheumatol. 1975. PMID: 241174 German.
-
[Antiphlogistic effect of salicylic acid and its derivatives].Fortschr Med. 1993 Nov 30;111(33):530-2. Fortschr Med. 1993. PMID: 8307537 Review. German.
-
[Nonsteroid antirheumatic agents].Z Gesamte Inn Med. 1977 Jul 15;32(14):333-7. Z Gesamte Inn Med. 1977. PMID: 335681 Review. German.